Pharmaceutical Diagnostics R&D

Shaping the future of diagnostic imaging

Research and Development is central to what we do, underpinning our commitment to shaping the future of imaging diagnostics. We are innovating to bring to market imaging agents, and the technologies to support them, to help enhance diagnosis and monitoring across neurology, oncology and cardiology care pathways, tackling unmet needs - to help improve outcomes for customers and their patients.

Key Facts

24¹

countries in which we run clinical studies

8¹

new products in development

10,000+²

doses delivered for clinical trials worldwide since 2018

“We aim to address healthcare challenges by investing to develop products for precise diagnosis and to make informed treatment decisions. This development is led by our skilled global R&D team with focus on bringing new products to the market for precise, personalized care for patients.”

Dr. Paul Evans
Head of Global Research & Development with GE HealthCare’s Pharmaceutical Diagnostics segment

Precision care

Our aim is to enable practitioners to deliver precision care for their patients - through faster, better-informed, clinical decisions to aid diagnosis, monitoring and treatment planning. We also work with practitioners in research settings, providing a wide choice of diagnostic tracers to support their needs.

Our pipeline

We are innovating, to develop a pipeline of products to help meet today’s unmet needs.

Focus and expertise

We conduct preclinical and clinical programs in neurology, cardiology, oncology, and immuno-diagnostics. Our team specializes in chemistry, radiochemistry, pharmacology, clinical development, imaging technology, and digital/AI.

Global partnerships

We have research and development hubs in the US, UK, France, Sweden, Norway and China and partner with top academic sites in the Americas, Europe and Asia³.

Collaborate with us

We collaborate with universities, medical centers, and organizations to conduct clinical and nonclinical research and develop products. Contact us if you're working on radiopharmaceuticals for diagnosis and therapy.

References
1. Data on file - Research and Development - countries, new products - March 2025
2. Date on file - Clinical trial doses delivered worldwide 2018-2021 - October 2022
3. Data on file - Research and development hubs and academic sites - April 2025

JB03749UK